| Product Code: ETC9968298 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, the United States continued to rely on a diverse group of countries for its insulin API imports, with Austria, Metropolitan France, Italy, Germany, and Brazil emerging as the top exporters. Despite the steady flow of imports, the market remained highly competitive, with a very low concentration as indicated by the HHI. The industry experienced a significant decline in CAGR from 2020-24 at -31.87%, with a further drop in growth rate from 2023-24 at -39.06%. This data suggests a challenging landscape for insulin API importers in the US market.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Insulin API Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Insulin API Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) Insulin API Market - Industry Life Cycle |
3.4 United States (US) Insulin API Market - Porter's Five Forces |
3.5 United States (US) Insulin API Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 United States (US) Insulin API Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 United States (US) Insulin API Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.8 United States (US) Insulin API Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 United States (US) Insulin API Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of diabetes in the United States |
4.2.2 Growing demand for insulin API due to advancements in insulin delivery devices |
4.2.3 Rising adoption of personalized medicine and biopharmaceuticals |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for insulin API production and distribution |
4.3.2 High costs associated with insulin API manufacturing |
4.3.3 Competition from alternative treatments such as oral antidiabetic drugs |
5 United States (US) Insulin API Market Trends |
6 United States (US) Insulin API Market, By Types |
6.1 United States (US) Insulin API Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Insulin API Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 United States (US) Insulin API Market Revenues & Volume, By Human Insulin, 2021- 2031F |
6.1.4 United States (US) Insulin API Market Revenues & Volume, By Insulin Analogue, 2021- 2031F |
6.2 United States (US) Insulin API Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Insulin API Market Revenues & Volume, By Fast- Acting, 2021- 2031F |
6.2.3 United States (US) Insulin API Market Revenues & Volume, By Intermediate Acting, 2021- 2031F |
6.2.4 United States (US) Insulin API Market Revenues & Volume, By Long- Acting, 2021- 2031F |
6.3 United States (US) Insulin API Market, By End-Users |
6.3.1 Overview and Analysis |
6.3.2 United States (US) Insulin API Market Revenues & Volume, By Clinics, 2021- 2031F |
6.3.3 United States (US) Insulin API Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.3.4 United States (US) Insulin API Market Revenues & Volume, By Home Healthcare, 2021- 2031F |
6.3.5 United States (US) Insulin API Market Revenues & Volume, By Others, 2021- 2031F |
6.4 United States (US) Insulin API Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 United States (US) Insulin API Market Revenues & Volume, By Direct Tender, 2021- 2031F |
6.4.3 United States (US) Insulin API Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.4.4 United States (US) Insulin API Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.4.5 United States (US) Insulin API Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.4.6 United States (US) Insulin API Market Revenues & Volume, By Others, 2021- 2031F |
7 United States (US) Insulin API Market Import-Export Trade Statistics |
7.1 United States (US) Insulin API Market Export to Major Countries |
7.2 United States (US) Insulin API Market Imports from Major Countries |
8 United States (US) Insulin API Market Key Performance Indicators |
8.1 Research and development investment in insulin API technologies |
8.2 Number of new insulin API product launches |
8.3 Adoption rate of insulin API in emerging healthcare facilities |
8.4 Number of collaborations and partnerships in the insulin API market |
8.5 Patent filings for insulin API innovations |
9 United States (US) Insulin API Market - Opportunity Assessment |
9.1 United States (US) Insulin API Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 United States (US) Insulin API Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 United States (US) Insulin API Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.4 United States (US) Insulin API Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 United States (US) Insulin API Market - Competitive Landscape |
10.1 United States (US) Insulin API Market Revenue Share, By Companies, 2024 |
10.2 United States (US) Insulin API Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here